(D) Cell viability of T24 cells transfected with control shRNA or shRNA and treated with a combination of TRAIL (2 ng/mL) and Andro (8 M)…
6d)
6d). Open in a separate window Fig. defect, contributed to the robust osteogenic capability of FReP cells in a challenging clinically relevant traumatic scenario were…